Published on 16/02/2017 5:28:12 PM | Source: Angel Broking Pvt Ltd

We maintain our NEUTRAL rating on Cadila Healthcare Ltd By Ms. Sarabjit Kour Nangra - Angel

Posted in Expert Views | #Cadila Healthcare Ltd #Expert Views #Pharma Sector #Sarabjit Kour Nangra


Below is the views on  Cadila Healthcare Ltd  By Ms. Sarabjit Kour Nangra (VP Research- Pharma, Angel Broking Pvt Ltd)

“Cadila Healthcare did not got any 483’s issued in favour of its Moriaya plant. This marks an important relief for the company, Moriaya plant is a significant contributor to the overall sales of the company and has around 74 pending approvals, of the > 200 ANDA’s pending approval ( at the company level). Though after the approval the plant will take time to get approvals for its ANDA’s from this plant and hence will have a long term positive impact on the company. Though we view the news as positive , we maintain our NEUTRAL rating on the stock, given the valuations.” 

 

Click here to open demat account   

For More Angel Broking Pvt Ltd Disclaimer   http://www.angelsecurities.in/disclaimer.aspx        

Above views are of the author and not of the website kindly read disclaimer